Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genosa is a biotechnology company specializing in the research and production of natural hydroxytyrosol, a potent antioxidant polyphenol derived from olives. Based in Spain, the company developed the patented Hytolive technology, which allows for the extraction of high-purity hydroxytyrosol without the use of solvents. Their products are primarily used as active ingredients in functional foods, dietary supplements, and pharmaceutical formulations aimed at cardiovascular health and inflammatory conditions. Genosa is recognized for its role in establishing the scientific basis for the EFSA health claim regarding olive oil polyphenols and the protection of LDL particles from oxidative damage. The company maintains a strong focus on clinical validation and intellectual property, holding numerous patents for its extraction processes and applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genosa.